术内用德克斯梅德托米丁对清细胞细胞癌进展的影响:一项回顾性队列研究
Ryan Wong1, Raj G Patel2, Nicolas Cortes-Mejia3
1Tilman J. Fertitta Family College of Medicine, University of Houston, Houston, TX, USA.
British journal of anaesthesia
|May 10, 2025
概括
德克斯梅德托米丁没有影响清细胞细胞癌 (RCC) 的存活率. 然而,瘤中ADRA2A基因表达较高与总生存时间较短有关,这表明ADRA2A在RCC中的潜在预后作用.
科学领域:
- 在瘤学瘤学.
- 麻醉学 麻醉学
- 遗传学 是一个遗传学.
背景情况:
- 德克斯梅德托米丁是一种α-2上腺素受体激动剂,由于其缓解麻醉的特性,在癌症手术中被用作辅助镇静剂.
- 清细胞细胞癌 (RCC) 是一种常见的癌类型.
研究的目的:
- 调查ADRA2基因表达和使用德克斯梅德托米丁与清细胞RCC患者的瘤结果之间的关联.
- 评估ADRA2A基因表达在清细胞RCC中的预后价值.
主要方法:
- 在公共数据库的形分析和对清洁细胞RCC患者的回顾性研究.
- 对ADRA2A表达,无复发生存 (RFS) 和整体生存 (OS) 的分析.
- 倾向性得分匹配和多变量分析被用于控制混因素.
主要成果:
- 瘤中的ADRA2A基因表达与RFS无关,但与较短的OS显著相关.
- 在1766名清细胞RCC患者的队列中,德克斯梅德托米丁的使用对复发率或死亡率没有显著影响.
- 德克斯梅德米丁没有显著影响RFS或OS.
结论:
- 术内使用德克斯梅德米丁似乎不会显著影响清晰细胞RCC的进展或患者的存活率.
- 需要进一步调查ADRA2A作为透明细胞RCC预后生物标志物的潜力.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
Depolarizing Blockers: Pharmocokinetics
296
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
296
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
151
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
151
